IBDEI0E7 ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19128,1,1,0)
 ;;=1^Comprehensive-Moderate
 ;;^UTILITY(U,$J,358.3,19128,1,2,0)
 ;;=2^99204
 ;;^UTILITY(U,$J,358.3,19129,0)
 ;;=99205^^128^1085^5
 ;;^UTILITY(U,$J,358.3,19129,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19129,1,1,0)
 ;;=1^Comprehensive-High Complex
 ;;^UTILITY(U,$J,358.3,19129,1,2,0)
 ;;=2^99205
 ;;^UTILITY(U,$J,358.3,19130,0)
 ;;=99212^^128^1086^2
 ;;^UTILITY(U,$J,358.3,19130,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19130,1,1,0)
 ;;=1^Problem Focused 
 ;;^UTILITY(U,$J,358.3,19130,1,2,0)
 ;;=2^99212
 ;;^UTILITY(U,$J,358.3,19131,0)
 ;;=99213^^128^1086^3
 ;;^UTILITY(U,$J,358.3,19131,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19131,1,1,0)
 ;;=1^Expanded Prob Focused 
 ;;^UTILITY(U,$J,358.3,19131,1,2,0)
 ;;=2^99213
 ;;^UTILITY(U,$J,358.3,19132,0)
 ;;=99214^^128^1086^4
 ;;^UTILITY(U,$J,358.3,19132,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19132,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,19132,1,2,0)
 ;;=2^99214
 ;;^UTILITY(U,$J,358.3,19133,0)
 ;;=99215^^128^1086^5
 ;;^UTILITY(U,$J,358.3,19133,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19133,1,1,0)
 ;;=1^Comprehensive 
 ;;^UTILITY(U,$J,358.3,19133,1,2,0)
 ;;=2^99215
 ;;^UTILITY(U,$J,358.3,19134,0)
 ;;=99241^^128^1087^1
 ;;^UTILITY(U,$J,358.3,19134,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19134,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,19134,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,19135,0)
 ;;=99242^^128^1087^2
 ;;^UTILITY(U,$J,358.3,19135,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19135,1,1,0)
 ;;=1^Expanded Problem Focused
 ;;^UTILITY(U,$J,358.3,19135,1,2,0)
 ;;=2^99242
 ;;^UTILITY(U,$J,358.3,19136,0)
 ;;=99243^^128^1087^3
 ;;^UTILITY(U,$J,358.3,19136,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19136,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,19136,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,19137,0)
 ;;=99244^^128^1087^4
 ;;^UTILITY(U,$J,358.3,19137,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19137,1,1,0)
 ;;=1^Comprehensive - Moderate
 ;;^UTILITY(U,$J,358.3,19137,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,19138,0)
 ;;=99245^^128^1087^5
 ;;^UTILITY(U,$J,358.3,19138,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,19138,1,1,0)
 ;;=1^Comprehensive - High
 ;;^UTILITY(U,$J,358.3,19138,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,19139,0)
 ;;=581.81^^129^1088^14
 ;;^UTILITY(U,$J,358.3,19139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19139,1,4,0)
 ;;=4^581.81
 ;;^UTILITY(U,$J,358.3,19139,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,19139,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,19140,0)
 ;;=583.81^^129^1088^13
 ;;^UTILITY(U,$J,358.3,19140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19140,1,4,0)
 ;;=4^583.81
 ;;^UTILITY(U,$J,358.3,19140,1,5,0)
 ;;=5^Nephritis
 ;;^UTILITY(U,$J,358.3,19140,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,19141,0)
 ;;=710.1^^129^1088^22
 ;;^UTILITY(U,$J,358.3,19141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19141,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,19141,1,5,0)
 ;;=5^Systemic Sclerosis (Sclero Derma)
 ;;^UTILITY(U,$J,358.3,19141,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,19142,0)
 ;;=710.2^^129^1088^9
 ;;^UTILITY(U,$J,358.3,19142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19142,1,4,0)
 ;;=4^710.2
 ;;^UTILITY(U,$J,358.3,19142,1,5,0)
 ;;=5^Keratoconjuctiviis Sicca(Sjogren)
 ;;^UTILITY(U,$J,358.3,19142,2)
 ;;=^192145
 ;;^UTILITY(U,$J,358.3,19143,0)
 ;;=710.3^^129^1088^3
 ;;^UTILITY(U,$J,358.3,19143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19143,1,4,0)
 ;;=4^710.3
 ;;^UTILITY(U,$J,358.3,19143,1,5,0)
 ;;=5^Dermatomyositis
 ;;^UTILITY(U,$J,358.3,19143,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,19144,0)
 ;;=710.4^^129^1088^16
 ;;^UTILITY(U,$J,358.3,19144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19144,1,4,0)
 ;;=4^710.4
 ;;^UTILITY(U,$J,358.3,19144,1,5,0)
 ;;=5^Polymyositis
 ;;^UTILITY(U,$J,358.3,19144,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,19145,0)
 ;;=710.9^^129^1088^2
 ;;^UTILITY(U,$J,358.3,19145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19145,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,19145,1,5,0)
 ;;=5^Connective Tissue Disease Unsp
 ;;^UTILITY(U,$J,358.3,19145,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,19146,0)
 ;;=443.0^^129^1088^18
 ;;^UTILITY(U,$J,358.3,19146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19146,1,4,0)
 ;;=4^443.0
 ;;^UTILITY(U,$J,358.3,19146,1,5,0)
 ;;=5^Raynaud'S Syndrome
 ;;^UTILITY(U,$J,358.3,19146,2)
 ;;=^103165
 ;;^UTILITY(U,$J,358.3,19147,0)
 ;;=714.0^^129^1088^20
 ;;^UTILITY(U,$J,358.3,19147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19147,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,19147,1,5,0)
 ;;=5^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,19147,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,19148,0)
 ;;=714.9^^129^1088^8
 ;;^UTILITY(U,$J,358.3,19148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19148,1,4,0)
 ;;=4^714.9
 ;;^UTILITY(U,$J,358.3,19148,1,5,0)
 ;;=5^Inflammatory Arth., Seronegative
 ;;^UTILITY(U,$J,358.3,19148,2)
 ;;=^272122
 ;;^UTILITY(U,$J,358.3,19149,0)
 ;;=274.9^^129^1088^4
 ;;^UTILITY(U,$J,358.3,19149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19149,1,4,0)
 ;;=4^274.9
 ;;^UTILITY(U,$J,358.3,19149,1,5,0)
 ;;=5^Gout Nos
 ;;^UTILITY(U,$J,358.3,19149,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,19150,0)
 ;;=733.40^^129^1088^12
 ;;^UTILITY(U,$J,358.3,19150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19150,1,4,0)
 ;;=4^733.40
 ;;^UTILITY(U,$J,358.3,19150,1,5,0)
 ;;=5^Necrosis/Aseptic
 ;;^UTILITY(U,$J,358.3,19150,2)
 ;;=^81763
 ;;^UTILITY(U,$J,358.3,19151,0)
 ;;=734.^^129^1088^15
 ;;^UTILITY(U,$J,358.3,19151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19151,1,4,0)
 ;;=4^734.
 ;;^UTILITY(U,$J,358.3,19151,1,5,0)
 ;;=5^Pes Planus
 ;;^UTILITY(U,$J,358.3,19151,2)
 ;;=^46756
 ;;^UTILITY(U,$J,358.3,19152,0)
 ;;=736.70^^129^1088^17
 ;;^UTILITY(U,$J,358.3,19152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19152,1,4,0)
 ;;=4^736.70
 ;;^UTILITY(U,$J,358.3,19152,1,5,0)
 ;;=5^Pronated Feet
 ;;^UTILITY(U,$J,358.3,19152,2)
 ;;=^123805
 ;;^UTILITY(U,$J,358.3,19153,0)
 ;;=337.20^^129^1088^19
 ;;^UTILITY(U,$J,358.3,19153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19153,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,19153,1,5,0)
 ;;=5^Reflex Sympathetic Dystrophy-Unsp
 ;;^UTILITY(U,$J,358.3,19153,2)
 ;;=^295799
 ;;^UTILITY(U,$J,358.3,19154,0)
 ;;=710.0^^129^1088^21
 ;;^UTILITY(U,$J,358.3,19154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19154,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,19154,1,5,0)
 ;;=5^Syst Lupus Erythematosis
 ;;^UTILITY(U,$J,358.3,19154,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,19155,0)
 ;;=695.4^^129^1088^11
 ;;^UTILITY(U,$J,358.3,19155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19155,1,4,0)
 ;;=4^695.4
 ;;^UTILITY(U,$J,358.3,19155,1,5,0)
 ;;=5^Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,19155,2)
 ;;=^72141
 ;;^UTILITY(U,$J,358.3,19156,0)
 ;;=359.6^^129^1088^7
 ;;^UTILITY(U,$J,358.3,19156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19156,1,4,0)
 ;;=4^359.6
 ;;^UTILITY(U,$J,358.3,19156,1,5,0)
 ;;=5^Infl Myopathy In Oth Dis
 ;;^UTILITY(U,$J,358.3,19156,2)
 ;;=^268543
 ;;^UTILITY(U,$J,358.3,19157,0)
 ;;=726.32^^129^1088^10
 ;;^UTILITY(U,$J,358.3,19157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19157,1,4,0)
 ;;=4^726.32
 ;;^UTILITY(U,$J,358.3,19157,1,5,0)
 ;;=5^Lateral Epicondylitis
 ;;^UTILITY(U,$J,358.3,19157,2)
 ;;=^117801
 ;;^UTILITY(U,$J,358.3,19158,0)
 ;;=274.02^^129^1088^5
 ;;^UTILITY(U,$J,358.3,19158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19158,1,4,0)
 ;;=4^274.02
 ;;^UTILITY(U,$J,358.3,19158,1,5,0)
 ;;=5^Gouty Atroph,Chronic W/O Tophiceous
 ;;^UTILITY(U,$J,358.3,19158,2)
 ;;=^338227
 ;;^UTILITY(U,$J,358.3,19159,0)
 ;;=274.03^^129^1088^6
 ;;^UTILITY(U,$J,358.3,19159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19159,1,4,0)
 ;;=4^274.03
 ;;^UTILITY(U,$J,358.3,19159,1,5,0)
 ;;=5^Gouty Atroph,Chronic With Tophiceous
 ;;^UTILITY(U,$J,358.3,19159,2)
 ;;=^338228
 ;;^UTILITY(U,$J,358.3,19160,0)
 ;;=274.01^^129^1088^3.5
 ;;^UTILITY(U,$J,358.3,19160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19160,1,4,0)
 ;;=4^274.01
 ;;^UTILITY(U,$J,358.3,19160,1,5,0)
 ;;=5^Acute Gouty Arthropathy
 ;;^UTILITY(U,$J,358.3,19160,2)
 ;;=^338226
 ;;^UTILITY(U,$J,358.3,19161,0)
 ;;=1^1^129^1089^1^OSTEOARTHROSIS, GENERALIZED^1
 ;;^UTILITY(U,$J,358.3,19161,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,19162,0)
 ;;=715.00^^129^1089^2
 ;;^UTILITY(U,$J,358.3,19162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19162,1,4,0)
 ;;=4^715.00
 ;;^UTILITY(U,$J,358.3,19162,1,5,0)
 ;;=5^General Osteoarthrosis
 ;;^UTILITY(U,$J,358.3,19162,2)
 ;;=^272125
 ;;^UTILITY(U,$J,358.3,19163,0)
 ;;=715.04^^129^1089^1
 ;;^UTILITY(U,$J,358.3,19163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19163,1,4,0)
 ;;=4^715.04
 ;;^UTILITY(U,$J,358.3,19163,1,5,0)
 ;;=5^Gen Osteoarthros-Hand
 ;;^UTILITY(U,$J,358.3,19163,2)
 ;;=^272126
 ;;^UTILITY(U,$J,358.3,19164,0)
 ;;=12^1^129^1089^3^LOCALIZED,PRIMARY^1^1
 ;;^UTILITY(U,$J,358.3,19164,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,19165,0)
 ;;=715.10^^129^1089^31
 ;;^UTILITY(U,$J,358.3,19165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19165,1,4,0)
 ;;=4^715.10
 ;;^UTILITY(U,$J,358.3,19165,1,5,0)
 ;;=5^Loc Prim Osteoart-Unspec
 ;;^UTILITY(U,$J,358.3,19165,2)
 ;;=^272129
 ;;^UTILITY(U,$J,358.3,19166,0)
 ;;=715.11^^129^1089^30
 ;;^UTILITY(U,$J,358.3,19166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19166,1,4,0)
 ;;=4^715.11
 ;;^UTILITY(U,$J,358.3,19166,1,5,0)
 ;;=5^Loc Prim Osteoart-Shlder
 ;;^UTILITY(U,$J,358.3,19166,2)
 ;;=^272130
 ;;^UTILITY(U,$J,358.3,19167,0)
 ;;=715.12^^129^1089^32
 ;;^UTILITY(U,$J,358.3,19167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19167,1,4,0)
 ;;=4^715.12
 ;;^UTILITY(U,$J,358.3,19167,1,5,0)
 ;;=5^Loc Prim Osteoart-Up/Arm
 ;;^UTILITY(U,$J,358.3,19167,2)
 ;;=^272131
 ;;^UTILITY(U,$J,358.3,19168,0)
 ;;=715.13^^129^1089^25
 ;;^UTILITY(U,$J,358.3,19168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19168,1,4,0)
 ;;=4^715.13
